News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
640,527 Results
Type
Article (20320)
Company Profile (204)
Press Release (619999)
Multimedia
Podcasts (56)
Webinars (14)
Section
Business (211449)
Career Advice (708)
Deals (31904)
Drug Delivery (62)
Drug Development (64243)
Employer Resources (58)
FDA (13388)
Job Trends (11699)
News (299734)
Policy (23113)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (7)
Academia (1534)
Accelerated approval (37)
ADA (26)
Adcomms (2)
Allergies (168)
Alliances (47164)
ALS (167)
Alzheimer's disease (1325)
Antibody-drug conjugate (ADC) (476)
Approvals (14220)
Artificial intelligence (798)
ASCO (205)
Autoimmune disease (324)
Automation (68)
Bankruptcy (299)
Belgium (14)
Best Places to Work (9327)
BIO (51)
Biologics (48)
BIOSECURE Act (7)
Biosimilars (155)
BioSpace Insights (100)
Biotechnology (138)
Bispecific (15)
Bladder cancer (173)
Brain cancer (60)
Breast cancer (664)
Cancer (5316)
Cardiovascular disease (356)
Career advice (623)
Career pathing (14)
CAR-T (331)
CDC (14)
CDMO (116)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (864)
Cervical cancer (49)
Clinical research (57666)
Collaboration (2228)
Commercialization (30)
Company closure (1)
Compensation (1656)
Complete response letters (43)
COVID-19 (1518)
CRISPR (122)
CRO (1)
C-suite (1246)
Cystic fibrosis (121)
Data (7910)
Decentralized trials (3)
Denatured (28)
Depression (131)
Dermatology (113)
Diabetes (505)
Diagnostics (6674)
Digital health (70)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (347)
Drug pricing (24)
Drug shortages (8)
Duchenne muscular dystrophy (218)
Earnings (84876)
Editorial (12)
Employer branding (9)
Employer resources (54)
Events (109538)
Executive appointments (1066)
Eye disease (6)
FDA (17310)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (20)
Frontotemporal dementia (33)
Funding (1700)
Gene editing (249)
Generative AI (61)
Gene therapy (623)
GLP-1 (526)
Government (1849)
Grass and pollen (4)
Guidances (358)
Healthcare (14523)
Hematology (123)
HIV (78)
Huntington's disease (31)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (88)
Immunology and inflammation (153)
Immuno-oncology (85)
Indications (219)
Infectious disease (1819)
Inflammatory bowel disease (173)
Inflation Reduction Act (6)
Influenza (132)
Intellectual property (331)
Interviews (85)
IPO (14986)
IRA (10)
Job creations (2752)
Job search strategy (558)
JPM (22)
Kidney cancer (20)
Kidney disease (79)
Labor market (34)
Layoffs (181)
Leadership (9)
Legal (6034)
Licensing (56)
Liver cancer (76)
Longevity (38)
Lung cancer (680)
Lung diease (10)
Lymphoma (369)
Machine learning (63)
Management (21)
Manufacturing (1123)
Marketing (20)
MASH (145)
Medical affairs (2)
Medical device (13780)
Medtech (14068)
Mergers & acquisitions (18304)
Metabolic disorders (1016)
mRNA (222)
Multiple sclerosis (151)
Multispecific (4)
NASH (7)
Netherlands (9)
Neurodegenerative disease (369)
Neuropsychiatric disorders (56)
Neuroscience (2626)
Neurotech (1)
NextGen: Class of 2026 (5050)
Non-profit (2037)
Now hiring (24)
Obesity (329)
Opinion (124)
Ovarian cancer (211)
Pain (232)
Pancreatic cancer (316)
Parkinson's disease (321)
Partnered (27)
Patents (656)
Patient advocacy (2)
Patient recruitment (755)
Patient selection (45)
Peanut (64)
People (53568)
Peptides (17)
Pharmaceutical (41)
Pharmacy benefit managers (15)
Phase 1 (19145)
Phase 2 (25692)
Phase 3 (17402)
Pipeline (10719)
Policy (80)
Postmarket research (1729)
Preclinical (8245)
Press Release (70)
Prostate cancer (286)
Psychedelics (13)
Radioligand (1)
Radiopharmaceuticals (348)
Rare diseases (847)
Real estate (4888)
Recruiting (25)
Regenerative medicine (15)
Regulatory (19989)
Reports (35)
Research institute (1593)
Resumes & cover letters (107)
Rett syndrome (51)
RNA editing (22)
RSV (67)
Schizophrenia (127)
Series A (311)
Series B (205)
Service/supplier (6)
Sickle cell disease (79)
Special edition (2)
Spinal muscular atrophy (111)
Sponsored (28)
Startups (3318)
State (2)
Stem cells (2)
Stomach cancer (4)
Substance use disorders (17)
Supply chain (88)
Switzerland (1)
Tariffs (13)
The Weekly (26)
Vaccines (745)
Venture capital (70)
Weight loss (120)
Wet AMD (2)
Women's health (126)
Worklife (4)
Date
Today (76)
Last 7 days (506)
Last 30 days (2102)
Last 365 days (25530)
2026 (20147)
2025 (25192)
2024 (30111)
2023 (34727)
2022 (45180)
2021 (48663)
2020 (45606)
2019 (36325)
2018 (27261)
2017 (27205)
2016 (26238)
2015 (32734)
2014 (27760)
2013 (23741)
2012 (25701)
2011 (26044)
2010 (24901)
Location
Africa (456)
Alabama (96)
Alaska (6)
Arizona (385)
Arkansas (17)
Asia (33815)
Australia (5285)
California (14535)
Canada (3944)
China (1209)
Colorado (642)
Connecticut (583)
Delaware (319)
Europe (64501)
Florida (2214)
Georgia (475)
Hawaii (4)
Idaho (60)
Illinois (1117)
India (97)
Indiana (465)
Iowa (26)
Japan (651)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (40)
Maryland (1606)
Massachusetts (10140)
Michigan (424)
Minnesota (787)
Mississippi (6)
Missouri (153)
Montana (31)
Nebraska (19)
Nevada (148)
New Hampshire (89)
New Jersey (3400)
New Mexico (27)
New York (3659)
North Carolina (1763)
North Dakota (12)
Northern California (7297)
Ohio (424)
Oklahoma (23)
Oregon (30)
Pennsylvania (2754)
Puerto Rico (30)
Rhode Island (55)
South America (728)
South Carolina (97)
South Dakota (1)
Southern California (5994)
Tennessee (213)
Texas (2432)
United States (49732)
Utah (453)
Vermont (2)
Virginia (256)
Washington D.C. (53)
Washington State (1175)
West Virginia (3)
Wisconsin (166)
Wyoming (2)
640,527 Results for "nanostring technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
NanoString Technologies to Be Acquired by Bruker Corporation
NanoString Technologies, Inc. (“NanoString” or “the Company”) today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global life science analytical instrument company, for approximately $392.6 million in cash consideration, plus the assumption of certain liabilities.
April 17, 2024
·
6 min read
Press Releases
AustinPx’s KinetiSol™ Technology Receives FDA Advanced Manufacturing Technology Designation
Designation supports earlier FDA engagement and greater regulatory predictability for pharma and biotech sponsors using formulation and manufacturing technology to enable their drug candidates
September 25, 2026
·
1 min read
Press Releases
Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC.
October 12, 2026
·
1 min read
BioForest
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
NanoString Technologies, Inc. announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager.
January 7, 2024
·
6 min read
Deals
Bruker Completes Asset Acquisition of NanoString Business
Bruker Corporation announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis.
May 6, 2024
·
7 min read
Business
NanoString Technologies Releases Operating Results for Third Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023.
November 6, 2023
·
17 min read
Deals
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
NanoString Technologies, Inc. announced that it has reached an agreement with Patient Square Capital, a prominent health care investment firm, pursuant to which Patient Square will serve as the “stalking horse” bidder in conjunction with a court-supervised sales process.
March 10, 2024
·
7 min read
Press Releases
Tulavi Therapeutics Awarded Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc.
September 28, 2026
·
4 min read
Press Releases
Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System
September 22, 2026
·
4 min read
Deals
Bruker to Acquire the NanoString Business in an Asset Deal
Bruker Corporation announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of solutions for spatial transcriptomics and gene expression analysis.
April 22, 2024
·
7 min read
1 of 64,053
Next